Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: Pooling of three British Health Surveys

Journal of Hepatology

Volumn 57, Issue 5, 2012, Pages 1083-1089

  Kengne, Andre Pascal ^a,b,c   Czernichow, Sébastien ^d   Stamatakis, Emmanuel ^e   Hamer, Mark ^e   Batty, G David ^e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular disease; Diabetes mellitus; Gamma glutamyltransferase; Prediction

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AGED; ALGORITHMS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; GREAT BRITAIN; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84867574775     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.06.034     Document Type: Article

References (29)

1. International Diabetes Federation, editor. Diabetes Atlas. 5th ed. Brussels; 2011.
2. S. Czernichow, A.P. Kengne, E. Stamatakis, M. Hamer, and G.D. Batty Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk? Evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies Obes Rev 12 2011 680 687
3. Asia Pacific Cohort Studies Collaboration The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region Diabetes Care 26 2003 360 366
4. C.J. Nolan, P. Damm, and M. Prentki Type 2 diabetes across generations: from pathophysiology to prevention and management Lancet 378 2011 169 181
5. Asia Pacific Cohort Studies Collaboration Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region J Hypertens 25 2007 1205 1213
6. Asia Pacific Cohort Studies Collaboration Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region Diabetologia 50 2007 2289 2297
7. Asia Pacific Cohort Studies Collaboration Smoking, diabetes and cardiovascular diseases in men in the Asia-Pacific region J Diabetes 1 2009 173 181
8. T.H. Dent Predicting the risk of coronary heart disease. II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction Atherosclerosis 213 2010 352 362
9. E.G. Giannini, R. Testa, and V. Savarino Liver enzyme alteration: a guide for clinicians CMAJ 172 2005 367 379
10. G. Targher Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review Clin Chem Lab Med 48 2010 147 157
11. A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G.D. Smith, and D.A. Lawlor Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis Arterioscler Thromb Vasc Biol 27 2007 2729 2735
12. M. Monami, D. Balzi, C. Lamanna, C. Melani, C. Cocca, and E. Lotti Prognostic value of serum liver enzymes levels in type 2 diabetic patients Diabetes Metab Res Rev 23 2007 625 630
13. D. Sluik, J.W. Beulens, C. Weikert, S. van Dieren, A.M. Spijkerman, and A.D. van der Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus Diabetes Metab Res Rev 28 2012 284 288
14. Scottish Health Survey Publications. The Scottish Government Statistics [cited 2011 1.07]. Available from: http://www.scotland.gov.uk/Topics/Statistics/ Browse/Health/scottish-health-survey/Publications.
15. Health Survey of England Cardiovascular disease 1998 The Stationary Office London 1999
16. D. Lin, L. Wei, and Z. Yin Checking the Cox model with cumulative sums of Martingales-based residuals Biometrika 80 2003 557 572
17. D.F. Easton, J. Peto, and A.G. Babiker Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group Stat Med 10 1991 1025 1035
18. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
19. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-112
20. D. Collett Modelling survival data in medical research 2nd ed. 2003 Chapman & Hall/CRC New York
21. D.W. Hosmer, T. Hosmer, S. Le Cessie, and S. Lemeshow A comparison of goodness-of-fit tests for the logistic regression model Stat Med 16 1997 965 980
22. D.H. Lee, K. Silventoinen, G. Hu, D.R. Jacobs Jr., P. Jousilahti, and J. Sundvall Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women Eur Heart J 27 2006 2170 2176
23. S.G. Wannamethee, L. Lennon, and A.G. Shaper The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes Atherosclerosis 201 2008 168 175
24. D.H. Lee, B. Buijsse, L. Steffen, J. Holtzman, R. Luepker, and D.R. Jacobs Jr. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey Eur J Cardiovasc Prev Rehabil 16 2009 16 20
25. M. Van Hemelrijck, W. Jassem, G. Walldius, I.S. Fentiman, N. Hammar, and M. Lambe Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study Eur J Cancer 47 2011 2033 2041
26. O. Turgut, and I. Tandogan Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward J Atheroscler Thromb 18 2011 177 181
27. J.E. Mason, R.D. Starke, and J.E. Van Kirk Gamma-glutamyl transferase: a novel cardiovascular risk biomarker Prev Cardiol 13 2010 36 41
28. C.E. Ruhl, and J.E. Everhart Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population Gastroenterology 136 477-485 2009 e411
29. C. Bianchi, G. Penno, S. Del Prato, and R. Miccoli Serum gamma-glutamyltransferase is not associated to peripheral arterial disease in type 2 diabetic patients: cross-sectional findings Atherosclerosis 203 2009 49 50